MEDACTA GROUP N news, videos and press releases - Page 3
For more news please use our advanced search feature.
MEDACTA GROUP N - More news...
MEDACTA GROUP N - More news...
- EQS-Adhoc: Medacta publishes 2021 Annual General Meeting invitation
- EQS-Adhoc: Publication of 2020 Annual Results
- EQS-News: Medacta Announces the Launch of MySpine for S2-Alar-Iliac Fixation and Further Enhances its MySolutions Personalized Ecosystem
- EQS-News: Medacta Adds the MyHip Planner and the MyHip Verifier Tools to its Personalized Medicine Solutions for Hip Replacement
- EQS-Adhoc: 2020 Preliminary unaudited top-line figures
- EQS-News: Medacta Announces Successful Completion of the First TKA Surgery in the U.S. with NextAR Augmented Reality-Based Surgical Platform
- EQS-Adhoc: Medacta Group SA announces the results of today's Extraordinary General Meeting
- EQS-Adhoc: Medacta Group SA proposes the election of Riccardo Braglia as new independent member of the Board of Directors at the Extraordinary General Meeting on 18 December 2020
- EQS-News: Medacta Expands its Knee Offerings with New SensiTiN System with Low Metal Ion Release
- EQS-News: Medacta Launches M.U.S.T. 2.0 Instrumentation to Expand its Offerings for Spine Pathologies
- EQS-News: Medacta Expands its Knee Portfolio with 3DMetal Femoral Cones for Knee Revision
- EQS-News: Medacta Expands its Partial Knee Replacement Solutions with MOTO Lateral Partial Knee System
- EQS-Adhoc: Publication of 2020 Half Year Results
- Medacta Announces Successful Completion of the First Australian Surgery with NextAR TKA Augmented Reality-Based Surgical Platform following TGA Approval
- Medacta Receives FDA Clearance for the Lateralized Glenosphere
- EQS-Adhoc: Medacta Half-year 2020 revenue equal to Euro 135M, down 11.1% over the prior year due to COVID-19 related deferrals of orthopedic elective surgeries. Good backlog recovery in June with a double-digit growth rate.
- EQS-Adhoc: Medacta to Introduce NextAR(TM): First FDA-Cleared Augmented Reality-Based Surgical Platform for Total Knee Replacement
- Medacta Announces First Hip Replacement Surgeries with New Quadra-P System
- Medacta Receives CE Marking for its Long Diaphysis and Stemless Metaphysis Implants for Shoulder Joint Replacement
- Medacta Announces First Surgery Utilizing Mecta-C Stand Alone Anterior Cervical Interbody Fusion Device and New Registrations
- Medacta Announces CE Marking for Multiple Sports Medicine Products and First Surgeries With MectaTap TI Anchor
- EQS-Adhoc: Medacta announces the results of today's Annual General Meeting
- Medacta Expands its Hip and Shoulder Portfolio with M-Vizion Hip Femoral Modular Revision System and Long Humeral Diaphysis
- EQS-Adhoc: Medacta announces pay cuts to BoD and GEM members and publishes 2020 AGM invitation
- Medacta Launches the MORE in Touch Program
- EQS-Adhoc: Publication of 2019 Annual Results
- EQS-Adhoc: Changes in the Board of Directors of Medacta Group SA
- Medacta Announces FDA Clearance for Mecta-C Stand Alone Anterior Cervical Interbody Fusion Device
- Medacta Announces FDA Clearance for Multiple Sports Medicine Products: MectaLock All-Suture Anchors, MectaTap Ti Suture Anchors and MectaFIX CL
- Medacta Spotlights Knee Sports Medicine and Knee Arthroplasty at the 2nd M.O.R.E. Australian Knee Symposium
